CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy

MLA

Antoine Azar, et al. “CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy.” AJR. American Journal of Roentgenology, vol. 216, no. 4, Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d7196003d61f411bcedf4c886bbf6884&authtype=sso&custid=ns315887.

APA

Antoine Azar, Bhavya Yarlagadda, Daniel E. Wessell, Hillary W. Garner, & Nicholas G. Rhodes. (2020). CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy. AJR. American Journal of Roentgenology, 216(4).

Chicago

Antoine Azar, Bhavya Yarlagadda, Daniel E. Wessell, Hillary W. Garner, and Nicholas G. Rhodes. 2020. “CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy.” AJR. American Journal of Roentgenology 216 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d7196003d61f411bcedf4c886bbf6884&authtype=sso&custid=ns315887.